| |
|
|
|
Omni Parker House, Boston, MA, USA
March 17-18, 2014
Pre-Conference Short Course: Long Non-Coding RNAs as Biomarkers Dinner Course: Exosomal microRNAs as Non-Invasive Biomarkers Keynote Presentation: Nanoparticles for Detection of miRNA Biomarkers and Delivery of miR-Based Therapeutics UTILITY OF MICRORNA BIOMARKERS IN DRUG DEVELOPMENT - Circulating miRNAs as Potential Biomarkers for Cardiovascular Toxicity
- MicroRNAs as Promising Biomarkers of Renal Injury
- MiRNAs as Circulating Biomarkers for Alzheimer’s Disease
- MicroRNAs Downregulated in Drug-Resistant Cancer Cells as Biomarkers and Therapeutic Targets for Drug Efficacy
MICRORNA BIOMARKERS AS CANCER DIAGNOSTICS - Advancing Molecular Diagnostics and Precision Medicine Using Non-Coding RNA Variants
- Tissue Slide-Based microRNA Diagnostics for Cancer Medicine
- MicroRNAs as Predictive and Prognostic Biomarkers in Colorectal Cancer
- Circulating Exosomal RNA as Diagnostic Markers and Real-Time Therapeutic Markers for Cancer
- MicroRNAs as Central Players in the Biology of the Tumor Microenvironment: When Decoding miRNA Riddles Leads to Personalized Medicine
MICRORNA AS DISEASE BIOMARKERS - Hepatitis C Virus-Induced Modulation of Host microRNAs Is No miRage: Novel Biomarkers for Liver Disease
- Urinary miRNA Patterns in Type 1 Diabetes: Implications for Prognosis and Pathogenesis of Diabetic Nephropathy
- Circulating microRNAs in Plasma as Predictive Biomarkers for Parkinson’s Disease: A New Paradigm
|
|
|
|
|
|
|
|
Organized by:
|
|
Cambridge Healthtech Institute |
|
|
Invited Speakers:
|
|
Speakers include: - Robert J. Lee, Ph.D., Professor, Pharmaceutics, OSU College of Pharmacy, The Ohio State University
- Pavan Kumar, Senior Scientist, Biomarkers and Personalized Medicine, Eisai
- Rounak Nassirpour, Principal Scientist, Drug Safety R&D, Pfizer
- James G. Falls, Manager, Discovery and Molecular Toxicology, GlaxoSmithKline
- Taosheng Chen, Ph.D., Associate Member and Director of HTS, Chemical Biology and Therapeutics, St. Jude Children’s Research Hospital
- Prasun J. Mishra, Ph.D., Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH
- Lorenzo F. Sempere, Ph.D., Research Assistant Professor, Medicine, Geisel School of Medicine, Dartmouth-Hitchcock Medical Center
- Jingfang Ju, Ph.D., Associate Professor, Co-Director of Translational Research, Pathology, Stony Brook University
- Douglas D. Taylor, Ph.D., Professor, Obstetrics, Gynecology, and Women’s Health, University of Louisville School of Medicine
- Muller Fabbri, M.D., Ph.D., Assistant Professor, Pediatrics and Molecular Microbiology & Immunology, University of Southern California Keck School of Medicine, Children’s Hospital Los Angeles
- Nelson Chau, Ph.D., Director, Target ID and Assays Group, Regulus Therapeutics
- John Paul Pezacki, Ph.D., Senior Research Officer and Group Leader, Life Sciences, National Research Council of Canada
- John P. Johnson, M.D., Professor, Medicine, Cell Biology and Physiology, University of Pittsburgh
- Christos Argyropoulos, M.D., Ph.D., Medical Affairs Consultant
- Sok Kean Khoo, Ph.D., Distinguished Associate Professor, Molecular Genomics, Department of Cell & Molecular Biology, GVSU Michigan
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
---
|
|
|
|
|
|
|
|
Registration:
|
|
Register Now
|
|
|
E-mail:
|
|
kwaterman@healthtech.com
|
|
|
|
|
|
|
|
|